The Ontario Physicians and Surgeons Discipline Tribunal ruled Jan. 28 that Ashwin Rajan Maharaj demonstrated incompetence and ...

A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...

GILBERT, Ariz., Jan. 14, 2026 /PRNewswire/ -- Strive Compounding Pharmacy, one of the nation's most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against ...

Economist Ludwig von Mises famously described economics as the study of human activity in a world of limited resources and unlimited wants. Central to his thinking was the idea that individuals must ...

The compounding program is designed to elevate pharmacy technicians to nationally recognized training standards. “Compounding pharmacies thrive when their teams operate at the top of their training ...

Investment gains achieved on small-but-steady savings will eventually eclipse your annual contributions of new money. Most of these gains, however, are only achieved near the end of your savings time ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...

Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...